26 Jul 2013 12:00
26 July 2013
Immunodiagnostic Systems Holdings PLC
AGM Statement
Immunodiagnostic Systems Holdings PLC ("the Company" or "the Group"), a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, will today hold its Annual General Meeting at 2pm at its registered office at 10 Didcot Way, Boldon Business Park, Boldon, Tyne & Wear, NE35 9PD.
At the meeting, Chairman, Dr. Anthony Martin, will make the following statement to shareholders.
"The Board is pleased to report that the Group has had an encouraging start to this financial year with financial performance in line with management expectations. We believe that the strategy we have to return the Group to growth is beginning to gain traction and the Board remains confident about the Company's future prospects."
For further information:
Immunodiagnostic Systems Holdings PLC | Tel : +44 (0)191 519 0660 |
Patrik Dahlen, Chief Executive Officer | |
Chris Yates, Finance Director
| |
Peel Hunt LLP | Tel : +44 (0)207 418 8900 |
James Steel | |
Dr Vijay Barathan | |
FTI Consulting |
Tel : +44 (0)207 831 3113 |
Ben Atwell | |
Simon Conway | |
Mo Noonan |
About Immunodiagnostic Systems Holdings PLC
The Group operates in the in-vitro diagnostics ("IVD") market by designing, manufacturing and selling immunoassay kits as well as selling and placing its automated analyser, the IDS-iSYS system. The IDS product range is used to measure or detect particular substances within a sample, thus aiding the diagnosis or monitoring of a disease or providing information for research studies.
http://www.idsplc.com